Cite
The anti-tumor activity of tangeretin in esophageal squamous cell carcinoma by inhibiting GLI2-mediated transcription of GPNMB.
MLA
Yang, Dong, et al. “The Anti-Tumor Activity of Tangeretin in Esophageal Squamous Cell Carcinoma by Inhibiting GLI2-Mediated Transcription of GPNMB.” PLoS ONE, vol. 19, no. 6, June 2024, pp. 1–18. EBSCOhost, https://doi.org/10.1371/journal.pone.0291531.
APA
Yang, D., Zhang, Q., Kuang, H., Liu, J., Wu, S., Wei, L., & Yao, W. (2024). The anti-tumor activity of tangeretin in esophageal squamous cell carcinoma by inhibiting GLI2-mediated transcription of GPNMB. PLoS ONE, 19(6), 1–18. https://doi.org/10.1371/journal.pone.0291531
Chicago
Yang, Dong, Quan Zhang, Haoyong Kuang, Jian Liu, Sen Wu, Li Wei, and Wenjian Yao. 2024. “The Anti-Tumor Activity of Tangeretin in Esophageal Squamous Cell Carcinoma by Inhibiting GLI2-Mediated Transcription of GPNMB.” PLoS ONE 19 (6): 1–18. doi:10.1371/journal.pone.0291531.